Cytokine soluble receptors in perinatal and early neonatal life

Mediators of Inflammation

Volumn 12, Issue 3, 2003, Pages 185-188

  Protonotariou, Efthimia ^a   Rizos, Demetrios ^a   Malamitsi Puchner, Ariadne ^a   Moira, Evangelia ^a   Sarandakou, Angeliki ^a   Salamalekis, Emmanuil ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Neonates; Soluble interleukin 2 receptor; Soluble interleukin 4 receptor; Soluble interleukin 6 receptor; Soluble tumor necrosis factor receptor I; Soluble tumor necrosis factor receptor II

Indexed keywords

CYTOKINE RECEPTOR; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4 RECEPTOR; INTERLEUKIN 6 RECEPTOR; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 2;

ARTICLE; CELL ACTIVATION; CELL MEMBRANE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOPLASM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FETOPLACENTAL UNIT; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOREGULATION; LABOR; MALE; NEWBORN; NEWBORN CARE; PERINATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEPTOR BINDING; REGULATORY MECHANISM; STATISTICAL SIGNIFICANCE; SYSTEMIC DISEASE; UMBILICAL CORD;

ADULT; AGING; FEMALE; FETAL BLOOD; HUMANS; INFANT, NEWBORN; LABOR, OBSTETRIC; MALE; OSMOLAR CONCENTRATION; PREGNANCY; RECEPTORS, CYTOKINE; SOLUBILITY;

EID: 0037765318     PISSN: 09629351     EISSN: None     Source Type: Journal    
DOI: 10.1080/0962935031000134914     Document Type: Article

References (22)

1. Steinke JW, Borish L. Th2 cytokines and asthma. Interleukin-4: its role in the pathogenensis of asthma, and targeting it for asthma treatment with interleukin-4 receptor antagonists. Respir Res 2001; 2: 66-70.
2. Gehr G, Braun T, Lesslauer W. Cytokines, receptors and inhibitors. Clin Invest 1992; 70: 64-69.
3. Austgulen R, Liabakk NB, Espevik T. Secretion of soluble receptors for tumor necrosis factor. An immunologic buffer mechanism during normal pregnancy? Tidsskr Nor Laegeforen 1992; 111: 3545-3547.
4. Rubin LA, Nelson DL. The soluble interleukin-2 receptor: biology, function, and clinical application. Ann Intern Med 1990; 113: 619-627.
5. Sarandakou A, Phocas I, Giannaki G, Rizos D, Davri Y, Zourlas PA. Immunomarkers in newborn infants. In: Cosmi EV, Di Renzo GC, eds. Proceedings of the 2nd World Congress of Perinatal Medicine, Monduzzi Editore, Bologna. 1993: 307-310.
6. MacDonald PC, Koga S, Casey ML. Decidual activation in parturition: examination of amniotic fluid for mediators of the inflammatory response. Ann NY Acad Sci 1991; 622: 315-330.
7. Mitchell MD, Trautman MS, Dudley DJ. Cytokine networking in the placenta. Placenta 1993; 14: 249-275.
8. Zola H, Ridings J, Elliott S, et al. Interleukin-2 receptor regulation and IL-2 function in the human infant. Hum Immunol 1998; 59: 615-624.
9. Mahida YR, Gallagher A, Kurlak L, Hawkey CJ. Plasma and tissue interleukin-2 receptor levels in inflammatory bowel disease. Clin Exp Immunol 1990; 82: 75-80.
10. Sarandakou A, Rizos D, Poulakis N, Phocas I. Immunomarkers in pleural effusions. Clin Chem Enzym Commun 1994; 6: 269-275.
11. Steis RG, Macron L, Clark J, Urba W, Long DL, Nelson DL, Maluish AE. Serum soluble IL-2 receptor as a tumor marker in patients with hairy cell leukemia. Blood 1988; 71: 1304-1309.
12. Poulakis N, Sarandakou A, Rizos D, Phocas I, Kontozoglou T, Polyzogopoulos D. Soluble interleukin-2 receptors and other markers in primary lung cancer. Cancer 1991; 68: 1045-1049.
13. Sarandakou A, Phocas I, Sikiotis K, et al. Cytokines in gynecological cancer. Anticancer Res 1997; 17: 3835-3839.
14. Sarandakou A, Agroyannis B, Rizos D, Kapetanaki A, Founda P, Phocas I, Koutsikos D. Soluble interleukin-2 receptors (sIL-2R) and b2-Microglobulin (b2-M) serum levels in renal transplant recipients (RTR). Dialysis Transplant 1993; 22: 246-250.
15. Schauer U, Schmitt M, Muller S, et al. Soluble interleukin-4 receptor in atopic children. Int Arch Allergy Immunol 1995; 108: 175-182.
16. de Moraes-Pinto MI, Vince GS, Flanagan BF, Hart CA, Johnson PM. Localization of IL-4 and IL-4 receptors in the human term placenta, decidua, and amniochorionic membranes. Immunology 1997; 90: 87-94.
17. Jokhi PP, King A, Loke YW. Cytokine production and cytokine receptor expression by cells of the human first trimester placental-uterine interface. Cytokine 1997; 9: 126-137.
18. Dame JB, Juul SE. The distribution of receptors for the proinflammatory cytokines interleukin (IL)-6 and IL-8 in the developing human fetus. Earl Hum Dev 2000; 58: 25-39.
19. Austgulen R, Liabakk NB, Lien E, Espevik T. Increased levels of soluble tumor necrosis factor-alpha receptors in serum from pregnant women and in serum and urine samples from newborns. Pediatr Res 1992; 33: 82-87.
20. Hata T, Kawamura T, Fujiwaki R, Aoki S, Hata K, Inada K. Interleukin-4, interleukin-10, and soluble tumor necrosis factor receptors in cord blood. Gynecol Obstet Invest 1997; 43: 155-157.
21. Opsjøn SL, Novick D, Wathen NC, Cope AP, Wallach D, Aderka D. Soluble tumor necrosis factor receptors and soluble interleukin-6 receptor in fetal and maternal sera, coelomic and amniotic fluids in normal and pre-eclamptic pregnancies. J Reprod Immunol 1995; 29: 119-134.
22. Kupferminc MJ, Peaceman AM, Aderka D, Wallach D, Socol ML. Soluble tumor necrosis factor receptors and interleukin-6 levels in patients with severe preeclampsia. Obstet Gynecol 1996; 88: 420-427.